Dr. Hlatky had argued Steward breached its contract with her when it spun off her research lab at St. Elizabeth Medical Center in 2013 to Genesys Research Institute, a nonprofit biotechnology firm based in Boston. After facing serious financial problems, Genesys closed Dr. Hlatky’s lab in September 2014 before filing for Chapter 11 bankruptcy. Her lab was liquidated — the equipment was auctioned off and thousands of containers that held cells, proteins and other biological research matter were incinerated.
Dr. Hlatky’s attorneys estimated that she will ultimately collect $34 million in payments from Steward, including interest.
“We feel vindicated,” Dr. Hlatky said of the verdict, according to the report.
Steward said the decision was “outrageous and unwarranted,” according to the report. The health system’s lawyers questioned Dr. Hlatky’s work, saying it was a “speculative research project that failed to produce any usable treatments for cancer patients,” and vowed to repeal the verdict.
Read the full report here.
More articles on legal and regulatory issues:
Pharmacy execs charged after 3 infants harmed by overly-potent painkillers
FCC fines man $120M for robocall spree that interfered with hospital communications network
8 latest healthcare industry lawsuits, settlements
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.